Addlife AB, commonly referred to as Addlife, is a prominent player in the life sciences industry, headquartered in Sweden (SE). Founded in 2016, the company has rapidly established itself as a key provider of products and services that enhance healthcare and laboratory operations across Europe. With a focus on diagnostics, medical technology, and laboratory equipment, Addlife offers a diverse range of core products that are distinguished by their quality and innovation. The company operates in several major regions, including Scandinavia and Central Europe, ensuring a robust presence in the market. Addlife's commitment to improving patient outcomes and supporting healthcare professionals has led to notable achievements, positioning it as a trusted partner in the life sciences sector. Through strategic acquisitions and a customer-centric approach, Addlife continues to expand its influence and deliver exceptional value in the healthcare landscape.
How does Addlife's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Addlife's score of 60 is higher than 76% of the industry. This can give you a sense of how well the company is doing compared to its peers.
In 2024, Addlife reported total carbon emissions of approximately 424.9 million kg CO2e. This figure includes Scope 1 emissions of about 5.1 million kg CO2e, Scope 2 emissions of approximately 1.6 million kg CO2e (market-based), and significant Scope 3 emissions totalling around 418.1 million kg CO2e. The Scope 3 emissions breakdown reveals major contributions from purchased goods and services (about 350.3 million kg CO2e) and business travel (approximately 3.2 million kg CO2e). Addlife has set ambitious climate commitments, aiming for carbon neutrality in its operations by 2030. The company has also established a target to reduce the intensity of emissions in Scope 1 and Scope 2 by 25% per SEK million in sales by 2025, using 2021 as the baseline year. This commitment reflects a proactive approach to mitigating climate impact and aligns with industry standards for sustainability. The emissions data is sourced directly from AddLife AB (publ) and is not cascaded from any parent organization. The company is actively working towards its reduction targets, demonstrating a commitment to environmental responsibility and sustainable practices in the healthcare sector.
Access structured emissions data, company-specific emission factors, and source documents
| 2022 | 2023 | 2024 | |
|---|---|---|---|
| Scope 1 | 3,966,000 | 0,000,000 | 0,000,000 |
| Scope 2 | 514,000 | 0,000,000 | 0,000,000 |
| Scope 3 | - | 00,000,000 | 000,000,000 |
Addlife's Scope 3 emissions, which increased significantly last year and increased significantly since 2023, demonstrating supply chain emissions tracking. Nearly all of their carbon footprint comes from suppliers and value chain emissions, representing nearly all emissions under the GHG Protocol, with "Purchased Goods and Services" being the largest emissions source at 84% of Scope 3 emissions.
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Addlife has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.


You're welcome to quote or reference data from this page, but please include a visible link back to this URL.
Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.